Reply: Pathophysiological, methodological, and statistical considerations in CGRP monoclonal antibody therapy: A comment on Imai et al

Journal of the Neurological Sciences 2026

View at publisher
Authors: Shungo Imai, Keiko Ihara, Nobuyuki Takahashi, Seiya Ohtani, Narumi Watanabe, Chisato Iba, Kei Ishizuchi, Ryo Takemura, Jin Nakahara, Satoko Hori, Tsubasa Takizawa
DOI: 10.1016/j.jns.2026.125802
Cited by: 1
References: 6

Fields of Study & Subjects

Statistical Methods in Clinical Trials Neuroendocrine Tumor Research Advances Diabetes Treatment and Management

Publication details

Journal / source
Journal of the Neurological Sciences
Publisher
Elsevier BV
Volume
483
Pages
125802–125802
Publication date
7 February 2026
Language
EN